Rituximab is a chimeric monoclonal antibody against CD20+ lymphocytes used to treat non-Hodgkin lymphoma. hematological and autoimmune diseases rheumatoid arthritis. systemic lupus erythematosus. thrombocytopenic purpura. https://www.knowall.blog/